Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 505

1.

Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.

Dolff S, Quandt D, Wilde B, Feldkamp T, Hua F, Cai X, Specker C, Kribben A, Kallenberg CG, Witzke O.

Arthritis Res Ther. 2010;12(4):R150. doi: 10.1186/ar3100. Epub 2010 Jul 23.

2.

CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.

Patschan S, Dolff S, Kribben A, Dürig J, Patschan D, Wilde B, Specker C, Philipp T, Witzke O.

Clin Exp Immunol. 2006 Aug;145(2):235-42.

3.

Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.

Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O.

Scand J Immunol. 2007 Nov;66(5):584-90. Epub 2007 Sep 14.

4.

Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.

Yang XY, Wang HY, Zhao XY, Wang LJ, Lv QH, Wang QQ.

J Clin Immunol. 2013 May;33(4):767-74. doi: 10.1007/s10875-013-9878-1. Epub 2013 Feb 23.

PMID:
23435610
5.

OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.

Farres MN, Al-Zifzaf DS, Aly AA, Abd Raboh NM.

Ann Saudi Med. 2011 Jan-Feb;31(1):29-34. doi: 10.4103/0256-4947.75775.

6.

Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.

Takasaki Y, Ogaki M, Abe K, Takeuchi K, Ando S, Tokano Y, Kobayashi S, Sekigawa I, Tsuda H, Hashimoto H.

J Rheumatol. 1998 Jun;25(6):1085-91.

PMID:
9632068
7.

Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.

Abo-Elenein A, Shaaban D, Gheith O.

Egypt J Immunol. 2008;15(2):135-43.

PMID:
20306696
8.

Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.

Cabrera CM, Urra JM, Carreño A, Zamorano J.

Scand J Immunol. 2013 Sep;78(3):306-12. doi: 10.1111/sji.12088.

9.

Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis.

Aten J, Roos A, Claessen N, Schilder-Tol EJ, Ten Berge IJ, Weening JJ.

J Am Soc Nephrol. 2000 Aug;11(8):1426-38.

10.
11.

Urinary T cells in active lupus nephritis show an effector memory phenotype.

Dolff S, Abdulahad WH, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2010 Nov;69(11):2034-41. doi: 10.1136/ard.2009.124636. Epub 2010 May 14.

PMID:
20472588
12.

Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.

Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, Kang I.

Arthritis Res Ther. 2010;12(2):R53. doi: 10.1186/ar2964. Epub 2010 Mar 24. Erratum in: Arthritis Res Ther. 2010;12(3):402.

13.

Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus.

Dolff S, Abdulahad WH, Westra J, Doornbos-van der Meer B, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2011;13(5):R157. doi: 10.1186/ar3474. Epub 2011 Sep 29.

14.

Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.

Cui HD, Qi ZM, Yang LL, Qi L, Zhang N, Zhang XL, Du SY, Jiang Y.

Clin Exp Immunol. 2011 Aug;165(2):163-71. doi: 10.1111/j.1365-2249.2011.04424.x. Epub 2011 Jun 2.

15.

Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.

Wong CK, Lit LC, Tam LS, Li EK, Lam CW.

Rheumatology (Oxford). 2005 Aug;44(8):989-94. Epub 2005 May 3.

PMID:
15870153
16.

Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Puwipirom H, Hirankarn N, Sodsai P, Avihingsanon Y, Wongpiyabovorn J, Palaga T.

Arthritis Res Ther. 2010;12(6):R215. doi: 10.1186/ar3194. Epub 2010 Nov 29.

17.

Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.

Ezzat M, El-Gammasy T, Shaheen K, Shokr E.

Lupus. 2011 Jul;20(8):845-54. doi: 10.1177/0961203311398513. Epub 2011 May 16.

PMID:
21576203
18.

[Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].

Cai XY, Luo M, Lin XJ, Xu YL, Tang C, Ye JH, Li WN, He ZX, Yu N.

Zhonghua Yi Xue Za Zhi. 2012 Feb 21;92(7):460-3. doi: 10.3760/cma.j.issn.00376-2491-2012.07.008. Chinese.

PMID:
22490966
19.

The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus.

Kwan BC, Tam LS, Lai KB, Lai FM, Li EK, Wang G, Chow KM, Li PK, Szeto CC.

Rheumatology (Oxford). 2009 Dec;48(12):1491-7. doi: 10.1093/rheumatology/kep255. Epub 2009 Sep 22.

PMID:
19773408
20.

CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.

Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, Manz R, Hiepe F, Radbruch A, Burmester GR, Riemekasten G.

Arthritis Rheum. 2009 Jan;60(1):199-206. doi: 10.1002/art.24136.

Supplemental Content

Support Center